Immuneering (NASDAQ: IMRX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Oppenheimer on Friday, April 1, 2022. The analyst firm set a price target for 25.00 expecting IMRX to rise to within 12 months (a possible 400.00% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Immuneering (NASDAQ: IMRX) is $5 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Immuneering.
Immuneering’s Q2 earnings are confirmed for Thursday, September 8, 2022.
There is no upcoming split for Immuneering.
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.